1. Home
  2. HOWL vs NRT Comparison

HOWL vs NRT Comparison

Compare HOWL & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • NRT
  • Stock Information
  • Founded
  • HOWL 2017
  • NRT 1975
  • Country
  • HOWL United States
  • NRT United States
  • Employees
  • HOWL N/A
  • NRT N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • NRT Oil & Gas Production
  • Sector
  • HOWL Health Care
  • NRT Energy
  • Exchange
  • HOWL Nasdaq
  • NRT Nasdaq
  • Market Cap
  • HOWL 47.1M
  • NRT 46.4M
  • IPO Year
  • HOWL 2021
  • NRT N/A
  • Fundamental
  • Price
  • HOWL $1.36
  • NRT $5.09
  • Analyst Decision
  • HOWL Strong Buy
  • NRT
  • Analyst Count
  • HOWL 3
  • NRT 0
  • Target Price
  • HOWL $8.33
  • NRT N/A
  • AVG Volume (30 Days)
  • HOWL 554.2K
  • NRT 20.3K
  • Earning Date
  • HOWL 08-07-2025
  • NRT 08-29-2025
  • Dividend Yield
  • HOWL N/A
  • NRT 9.44%
  • EPS Growth
  • HOWL N/A
  • NRT 24.05
  • EPS
  • HOWL N/A
  • NRT 0.59
  • Revenue
  • HOWL $1,143,000.00
  • NRT $6,184,173.00
  • Revenue This Year
  • HOWL N/A
  • NRT N/A
  • Revenue Next Year
  • HOWL N/A
  • NRT N/A
  • P/E Ratio
  • HOWL N/A
  • NRT $8.67
  • Revenue Growth
  • HOWL N/A
  • NRT 18.55
  • 52 Week Low
  • HOWL $0.60
  • NRT $3.88
  • 52 Week High
  • HOWL $4.18
  • NRT $6.75
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 60.96
  • NRT 54.10
  • Support Level
  • HOWL $1.25
  • NRT $4.65
  • Resistance Level
  • HOWL $1.44
  • NRT $5.03
  • Average True Range (ATR)
  • HOWL 0.10
  • NRT 0.19
  • MACD
  • HOWL 0.02
  • NRT 0.02
  • Stochastic Oscillator
  • HOWL 68.89
  • NRT 69.21

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

Share on Social Networks: